4//SEC Filing
Sinnreich Matthew Phillip 4
Accession 0001829126-22-017985
CIK 0001557376other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 6:00 AM ET
Size
11.8 KB
Accession
0001829126-22-017985
Insider Transaction Report
Form 4
Sinnreich Matthew Phillip
DirectorPresident and Acting CEO
Transactions
- Sale
Common Stock, $0.001 par value
2022-10-13$0.04/sh−20,000$800→ 6,976,000 total(indirect: See Footnote)
Footnotes (1)
- [F1]Represents shares of common stock held by Retrograde Investments, LLC, in which entity the Reporting Person is a minority holder and over which the Reporting Person has shared voting and dispositive power.
Documents
Issuer
Organicell Regenerative Medicine, Inc.
CIK 0001557376
Entity typeother
Related Parties
1- filerCIK 0001939708
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 6:00 AM ET
- Size
- 11.8 KB